Key result
Obesity with or without type 2 diabetes was associated with significantly higher serum betatrophin levels compared to healthy controls in females, but not in males.
Why the study?
Betatrophin plays a role in lipid metabolism, but associations between betatrophin and lipoprotein subfractions are poorly investigated.
Are serum betatrophin levels associated with lipoprotein subfractions in obese patients with and without type 2 diabetes?
Observational (n=169)
Are serum betatrophin levels associated with lipoprotein subfractions in obese patients with and without type 2 diabetes?
Serum betatrophin levels are elevated in obese patients and correlate with atherogenic lipoprotein subfractions, with notable gender differences in these associations.
Gender-specific betatrophin-lipoprotein correlations in obesity may aid CV risk stratification; leaves open clinical utility pending prospective validation.
Betatrophin, also known as angiopoietin-like protein 8 (ANGPTL8), mainly plays a role in lipid metabolism. To date, associations between betatrophin and lipoprotein subfractions are poorly investigated. For this study, 50 obese patients with type 2 diabetes (T2D) and 70 nondiabetic obese (NDO) subjects matched in gender, age, and body mass index (BMI) as well as 49 gender- and age-matched healthy, normal-weight controls were enrolled. Serum betatrophin levels were measured with ELISA, and lipoprotein subfractions were analyzed using Lipoprint gel electrophoresis. Betatrophin concentrations were found to be significantly higher in the T2D and NDO groups compared to the controls in all subjects and in females, but not in males. We found significant positive correlations between triglyceride, very low density lipoprotein (VLDL), large LDL (low density lipoprotein), small LDL, high density lipoprotein (HDL) -6-10 subfractions, and betatrophin, while negative correlations were detected between betatrophin and IDL, mean LDL size, and HDL-1-5. Proportion of small HDL was the best predictor of betatrophin in all subjects. Small LDL and large HDL subfractions were found to be the best predictors in females, while in males, VLDL was found to be the best predictor of betatrophin. Our results underline the significance of serum betatrophin measurement in the cardiovascular risk assessment of obese patients with and without T2D, but gender differences might be taken into consideration.
No takes yet. Share an insight, caveat, or question.
Lőrincz et al. (2023) conducted an observational in Obesity and Type 2 Diabetes (n=169). Obesity with or without type 2 diabetes vs. Healthy normal-weight controls was evaluated on Serum betatrophin levels and correlation with lipoprotein subfractions. Obesity with or without type 2 diabetes was associated with significantly higher serum betatrophin levels compared to healthy controls in females, but not in males.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: